Traws Pharma’s ICAR Poster Highlights Potency of COVID-19 Candidate
23. Mai 2024 08:00 ET
|
Traws Pharma, Inc.
Traws Pharma’s ICAR Poster Highlights Potency of COVID-19 Candidate
Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update
16. Mai 2024 09:29 ET
|
Traws Pharma, Inc.
Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update
Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy
07. Mai 2024 08:00 ET
|
Traws Pharma, Inc.
Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy